← Open Payments lookup

TIMOTHY ONEILL: Open Payments

NPI 1831161124 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$489 in 34 payments from 10 companies in 2025. Trend: 2023 $310 · 2024 $430 · 2025 $489

Food & beverage: $489
CompanyPaymentsAmount
Novo Nordisk Inc21$226
ABBVIE INC.3$76
Lilly USA, LLC2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Esperion Therapeutics, Inc.1$24
Xeris Pharmaceuticals, Inc.1$24
Tanabe Pharma America, Inc.1$21
Astellas Pharma US Inc1$21
PFIZER INC.1$16
GlaxoSmithKline, LLC.1$16

Products named: Ozempic, Rybelsus, VRAYLAR, MOUNJARO, CAPLYTA, Wegovy, NEXLETOL, GVOKE HYPOPEN.

Industry payments across NV — which companies pay providers there.